Reduction of paraquat-induced renal cytotoxicity by manganese and copper complexes of EGTA and EHPG.
Superoxide anion generation plays an important role in the development of paraquat toxicity. Although superoxide dismutase mimetics (SODm) have provided protection against organ injury involving generation of superoxide anions, they often suffer problems, e.g., regarding their bioavailability or potential pro-oxidant activity. The aim here was to investigate and compare the therapeutic potential of two novel SODm, manganese(II) and copper(II) complexes of the calcium chelator ethylenebis(oxyethylenenitrilo)tetraacetic acid (EGTA) and of the contrast agent ethylenebis(hydroxyphenylglycine) (EHPG), against paraquat-induced renal toxicity in vitro. Incubation of renal NRK-52E cells with paraquat (1 mM) for 24 h produced submaximal, yet significant, reduction in cellular viability and cell death and produced significant increases in superoxide anion and hydroxyl radical generation. Manganese and copper complexes of EGTA (10-100 microM) and EHPG (30-100 microM) reduced paraquat-induced renal cell toxicity and reduced superoxide anion and hydroxyl radical generation significantly. Manganese complexes displayed greater efficacy than copper complexes and, at equivalent concentrations, manganese complexed with EHPG provided the greatest protection. Furthermore, these metal complexes did not interfere with the uptake of [methyl-(14)C]paraquat into NRK-52E cells, suggesting that they provided protection against paraquat cytotoxicity via intracellular mechanisms. These complexes did not display cytotoxicity at the concentrations examined. Together, these results suggest that manganese and copper complexes of EGTA and EHPG, and especially the manganese-EHPG complex, could provide benefit against paraquat nephrotoxicity.
Samai
Mohamed
M
Department of Pharmacology and Therapeutics, University of Brighton, Brighton, East Sussex BN2 4GJ, UK.
Hague
Theresa
T
Naughton
Declan P
DP
Gard
Paul R
PR
Chatterjee
Prabal K
PK
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003300:Copper / Q000494:pharmacology*; D019610:Cytoprotection; D004533:Egtazic Acid / Q000494:pharmacology*; D005029:Ethylenediamines / Q000494:pharmacology*; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008345:Manganese / Q000494:pharmacology*; D010269:Paraquat / Q000633:toxicity*; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D013482:Superoxide Dismutase / Q000494:pharmacology
D005029:Ethylenediamines; D017382:Reactive Oxygen Species; C011813:ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid); D008345:Manganese; D004533:Egtazic Acid; D003300:Copper; D007770:L-Lactate Dehydrogenase; D013482:Superoxide Dismutase; D010269:Paraquat